After adaptive feeding, an orthotopic MDA-MB-231 breast tumor xenograft model was established, and the animal experimental protocol is shown in Figure 1A. Compared with the control group, KIN significantly decelerated tumor growth in a dose-dependent manner (Figure 1B–D). Here, KIN is linked to breast neoplasm.